中文名称: | AZD5582 | ||||
---|---|---|---|---|---|
英文名称: | AZD5582 | ||||
别名: | (S,S,2S,2′S)-N,N′-((1S,1′S,2R,2′R)-2,2′-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(2,3-dihydro-1H-indene-2,1-diyl))bis(1-((S)-2-cyclohexyl-2-((S)-2-(methylamino)propanamido)acetyl)-pyrrolidine-2-carboxamide) | ||||
CAS No: | 1258392-53-8 | 分子式: | C58H78N8O8 | 分子量: | 1015.29 |
CAS No: | 1258392-53-8 | ||||
分子式: | C58H78N8O8 | ||||
分子量: | 1015.29 |
基本信息
产品编号:A11272 |
|||||
产品名称:AZD5582 |
|||||
CAS: |
1258392-53-8 |
储存条件 |
粉末 |
2-8℃ |
四年 |
4℃ |
两年 |
||||
分子式: |
溶于液体 |
-80℃ |
六个月 |
||
分子量 |
1015.29 |
-20℃ |
一个月 |
||
化学名: |
|
||||
Solubility (25°C) |
体外 |
DMSO |
100mg/mL (98.49mM) |
||
Ethanol |
|
||||
Water |
|
||||
体内(现配现用) |
|
|
|||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
0.9849mL |
4.9247mL |
9.8494mL |
5mM |
0.1970mL |
0.9849mL |
1.9699mL |
10mM |
0.0985mL |
0.4925mL |
0.9849mL |
50mM |
0.0197mL |
0.0985mL |
0.1970mL |
生物活性
产品描述 |
是 IAP 拮抗剂,可以有效与 cIAP1,cIAP2 和 XIAP 的 BIR3 结构域结合, IC50 值分别为 15,21,15 nM。AZD5582 诱导凋亡 (apoptosis)。 |
||
靶点/IC50 |
cIAP1 |
XIAP |
cIAP2 |
15nM |
15nM |
21nM |
|
体外研究 |
AZD5582 (20nM; 48 hours) inhibits cell viability by cooperation with IFNγ or viral double-stranded RNA (dsRNA) in H1975 NSCLC cells.AZD5582 (20nM; 17 or 25 hours) downregulates cIAP-1, activates RIPK1 (upstream regulator of caspase-8), and triggers the activation of extrinsic (caspase-8) and intrinsic (caspase-9) apoptosis pathways, causing the cleavage of caspase-3 and caspase-7.AZD5582 (20nM; 48 hours) involves in apoptosis due to induction of cell death and active caspase-3/8 activities by AZD5582 and IFNγ co-treatment in HCC827 NSCLC cells. Cell Viability Assay |
||
Cell Line: |
H1975 NSCLC cell line |
||
Concentration: |
20nM |
||
Incubation Time: |
48 hours |
||
Result: |
Cooperated with IFNγ or viral double-stranded RNA (dsRNA) to inhibit cell viability even cell death. |
||
Apoptosis Analysis |
|||
Cell Line: |
HCC827 NSCLC cell line |
||
Concentration: |
20nM |
||
Incubation Time: |
48 hours |
||
Result: |
Had an inhibitory effect on cell viability by cooperating with IFNγ. |
||
Western Blot Analysis |
|||
Cell Line: |
H1975 NSCLC cell line |
||
Concentration: |
20 nM |
||
Incubation Time: |
17 or 25 hours |
||
Result: |
Down-regulated cIAP-1, activated RIPK1 (upstream regulator of caspase-8), triggered the cleavage (activation) of caspase-3,7,8 and 9. |
||
体内研究 |
AZD5582 (intravenous injection; 0.1-3.0mg/kg; once a week; 2 weeks) causes degradation of cIAP1 and caspase 3 cleavage in tumor cells, and after a two-week treatment, the tumors largely resolved; when the mice are given a medium dose (0.5mg/kg) of AZD5582, cIAP1 degrades after administration, but it takes a while time to reach apoptosis-inducing effect. |
||
Animal Model: |
MDA-MB-231 xenograft-bearing mice |
||
Dosage: |
0.1mg/kg, 0.5mg/kg, 3.0mg/kg |
||
Administration: |
Intravenous injection; once a week; 2 weeks |
||
Result: |
Resulted in cIAP1 degradation and caspase-3 cleavage within tumor cells and causes substantial tumor regressions following two weekly doses of 3.0mg/kg |
推荐实验方法(仅供参考)
细胞实验: |
|
细胞系 |
人胰癌细胞(BxPC-3, Miapaca-2, Panc-1, Panc0813, PL45, Capan-1, Capan-2, AsPC-1) |
浓度 |
0, 0.01, 0.1, 0.5μM |
处理时间 |
72h |
方法 |
收集转染了DNA或siRNA、或是AZD5582处理过的细胞,通过台盼蓝拒染实验检测细胞死亡(样本量至少在200~500个细胞间)。至于MTS检测,将胰癌细胞以1∼3 × 104 cells/well的密度接种于96孔微量滴定板,培养过夜后,用不同浓度的AZD5592处理细胞72小时。然后进行MTS检测。 |
动物实验: |
|
动物模型 |
移植瘤模型 (in Balb/c nude mice) |
剂量 |
3mg/kg |
给药处理 |
i.v. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )